102 related articles for article (PubMed ID: 9711782)
1. Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV.
Rivière Y; Buseyne F
Vaccine; 1998; 16(14-15):1420-2. PubMed ID: 9711782
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
Cheynier R; Langlade-Demoyen P; Marescot MR; Blanche S; Blondin G; Wain-Hobson S; Griscelli C; Vilmer E; Plata F
Eur J Immunol; 1992 Sep; 22(9):2211-7. PubMed ID: 1381309
[TBL] [Abstract][Full Text] [Related]
3. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
4. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers.
Buseyne F; Burgard M; Teglas JP; Bui E; Rouzioux C; Mayaux MJ; Blanche S; Rivière Y
AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1435-44. PubMed ID: 9824321
[TBL] [Abstract][Full Text] [Related]
5. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
[TBL] [Abstract][Full Text] [Related]
6. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
[TBL] [Abstract][Full Text] [Related]
7. Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy.
Ching N; Yang OO; Deville JG; Nielsen-Saines K; Ank BJ; Sim MS; Bryson YJ
Pediatr Res; 2007 Jun; 61(6):692-7. PubMed ID: 17426646
[TBL] [Abstract][Full Text] [Related]
8. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.
Luzuriaga K; Holmes D; Hereema A; Wong J; Panicali DL; Sullivan JL
J Immunol; 1995 Jan; 154(1):433-43. PubMed ID: 7995957
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survival.
Pollack H; Zhan MX; Safrit JT; Chen SH; Rochford G; Tao PZ; Koup R; Krasinski K; Borkowsky W
AIDS; 1997 Jan; 11(1):F9-13. PubMed ID: 9110069
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
11. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection.
Wasik TJ; Jagodzinski PP; Hyjek EM; Wustner J; Trinchieri G; Lischner HW; Kozbor D
J Immunol; 1997 Jun; 158(12):6029-36. PubMed ID: 9190958
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte activity in children infected with HIV.
Froebel KS; Aldhous MC; Mok JY; Hayley J; Arnott M; Peutherer JF
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S83-8. PubMed ID: 7865339
[TBL] [Abstract][Full Text] [Related]
13. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
14. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.
Pikora CA; Sullivan JL; Panicali D; Luzuriaga K
J Exp Med; 1997 Apr; 185(7):1153-61. PubMed ID: 9104802
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators.
Jin X; Roberts CG; Nixon DF; Cao Y; Ho DD; Walker BD; Muldoon M; Korber BT; Koup RA
J Infect Dis; 1998 Nov; 178(5):1317-26. PubMed ID: 9780251
[TBL] [Abstract][Full Text] [Related]
16. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
Rivière Y
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
[TBL] [Abstract][Full Text] [Related]
18. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA
J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022
[TBL] [Abstract][Full Text] [Related]
19. Evolution and transmission of stable CTL escape mutations in HIV infection.
Goulder PJ; Brander C; Tang Y; Tremblay C; Colbert RA; Addo MM; Rosenberg ES; Nguyen T; Allen R; Trocha A; Altfeld M; He S; Bunce M; Funkhouser R; Pelton SI; Burchett SK; McIntosh K; Korber BT; Walker BD
Nature; 2001 Jul; 412(6844):334-8. PubMed ID: 11460164
[TBL] [Abstract][Full Text] [Related]
20. In vitro measurement of cytotoxic T cell activity does not predict clinical progression in paediatric HIV disease--two case studies.
Froebel KS; Mok JY; Aldhous MC; Armitage MP; Arnott M; Reynolds LM; Peutherer JF; Burns SM
Clin Exp Immunol; 1997 Oct; 110(1):15-21. PubMed ID: 9353143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
